Bionic Pancreas: Closer to Fully Automated Insulin Delivery?

Results from the iLet Bionic Pancreas pivotal trial demonstrate that a system using a novel algorithm for automated insulin delivery may further ease patient burden.

Related Keywords

Florida ,United States ,Tampa ,United Kingdom ,West Midlands ,United Kingdom General ,American ,Royw Beck ,Amar Puttanna ,Jaeb Center ,Health Research Foundation ,Drug Administration ,American Diabetes Association ,Medtronic ,Let Bionic Pancreas ,Beta Bionics ,Insulin Only Bionic Pancreas Pivotal Trial ,Medscape Medical ,Medscape Medical News ,Diabetes Mellitus Type 1 ,Iabetes Mellitus Type I ,Type 1 Diabetes ,Diabetes Mellitus ,Insulin Analog ,Insulin Analogue ,Hypoglycemia ,Hemoglobin A1c ,Hemoglobin A1c Test ,Glycated Hemoglobin ,Glycosylated Hemoglobin ,Ba1c ,A1c ,B1c ,Lycohemoglobin ,Hb ,Iabetic Control Index ,1c Assay ,Endocrinology ,Ndocrine System ,Artificial Pancreas ,Hyperglycemia ,Insulin Pump ,Ontinuous Subcutaneous Insulin ,